Impact of Highly Effective CFTR Modulator Therapy on Physical Activity, Sleep, and Sinonasal Symptoms in Preschool Children with Cystic Fibrosis: A Prospective Single-Center Pilot Study
Advances in Respiratory Medicine · 05.06.2026 · 94 (3) · 36
DOI: 10.3390/arm94030036 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 05.06.2026. Verfasst von Stella Schellhorn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicin, Ulm University Medical Center, Ulm University, Eythstrasse 24, 89075 Ulm, Germany. Hauptthemen laut MEDLINE: Cystic Fibrosis, Exercise, Aminophenols, Quinolones. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Highly effective CFTR modulation with Elexacaftor/Tezacaftor/Ivacaftor (ETI) markedly improves clinical outcomes in people with cystic fibrosis (CF). Data on its effects on physical activity, sleep, sinonasal symptoms, and parent-perceived outcomes in preschool-aged children are limited.
Methods
In this prospective, observational, single-center cohort study, ten children with cystic fibrosis (aged 2–6 years) and at least one CFTR variant eligible for ETI were included. Data were collected using wrist-worn Garmin vívofit Junior 2 activity trackers and standardized questionnaires one month before ETI initiation and at 1, 3, 6, and 12 months after start of ETI. Outcomes included step count, minutes of moderate-to-vigorous physical activity, sleep parameters, sinonasal symptoms, and parental perceptions.
Results
ETI was well tolerated. Sweat chloride levels decreased significantly. Physical activity improved at 3 and 6 months (step count and active minutes/day; p < 0.05) but declined to near-baseline levels at 12 months. Parental assessments of physical and sporting performance showed sustained improvement. Sleep duration remained stable, with no changes in deep or light sleep phases or nighttime awakenings. Sinonasal symptoms remained low. Discussion & Conclusions: Preliminary findings of this exploratory pilot study show that improvement in physical activity after three and six months of ETI therapy might be attributable to seasonality, as therapy was started in winter months. No changes in sleep duration or sleep patterns are reassuring in this small cohort of young children with CF. ETI therapy was safe and well tolerated. Parental appraisal of their children’s physical performance improved after start of ETI. Longitudinal, controlled studies involving larger cohorts are required to validate these findings and to account for potential confounding factors, such as age-dependent changes and individual and environmental factors such as seasonal variation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Adolescent Medicin, Ulm University Medical Center, Ulm University, Eythstrasse 24, 89075 Ulm, Germany.
ORCID-Profile: Dorit Fabricius, Sebastian F N Bode
Zitieren
APA
Schellhorn, S., Schmidt, H., Janda, A., Gülke, D., Toth, M., Fabricius, D., & Bode, S. F. N. (2026). Impact of Highly Effective CFTR Modulator Therapy on Physical Activity, Sleep, and Sinonasal Symptoms in Preschool Children with Cystic Fibrosis: A Prospective Single-Center Pilot Study. Advances in Respiratory Medicine, 94(3), 36. https://doi.org/10.3390/arm94030036
Vancouver
Schellhorn S, Schmidt H, Janda A, Gülke D, Toth M, Fabricius D, et al. Impact of Highly Effective CFTR Modulator Therapy on Physical Activity, Sleep, and Sinonasal Symptoms in Preschool Children with Cystic Fibrosis: A Prospective Single-Center Pilot Study. Advances in Respiratory Medicine. 2026;94(3):36. doi:10.3390/arm94030036
BibTeX
@article{Schellhorn2026,
author = {Schellhorn, Stella and Schmidt, Hanna and Janda, Ales and Gülke, Doris and Toth, Monika and Fabricius, Dorit and Bode, Sebastian F N},
title = {Impact of Highly Effective CFTR Modulator Therapy on Physical Activity, Sleep, and Sinonasal Symptoms in Preschool Children with Cystic Fibrosis: A Prospective Single-Center Pilot Study},
journal = {Advances in Respiratory Medicine},
year = {2026},
volume = {94},
number = {3},
pages = {36},
doi = {10.3390/arm94030036}
}
EUVIMED